HomeInvestors HealthBristol Myers to report Q4 IPRD/licensing expense of $18M Bristol Myers to report Q4 IPRD/licensing expense of $18M By BOMAR ENT. January 7, 2025 FacebookTwitterPinterestWhatsApp Bristol Myers to report Q4 IPRD/licensing expense of $18M Source link Previous articleTesla Stock Price Levels to Watch After Volatile StretchNext articleInvest Like a Girl: Jump into the Stock Market, Reach Your Money Goals, and Build Wealth latest articles explore more Rapid Review: Anatomy Reference Guide (2005-07-01) He Lives Overseas, But His 3 Rentals Cash Flow While He Sleeps Dividend ETFs vs. Growth ETFs: The Battle for Wealth The Top AI Apps Consumers Are Actually Using The Stock Market Roadmap: 10 Steps to Smart Investing for Beginners Rubber Band Stocks: A Simple Strategy for Trading Stocks LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.